Over 100 years serving the Lord home and around the world
First Baptist Church
We are a church who's members come from many nations of origin to worship together!

Director of Hematologic Malignancies Research at the Sarah Cannon Study Institute.

Calistoga Pharmaceuticals to present data on it is CAL-101 inhibitor in the 51st ASH meeting Calistoga Pharmaceuticals, Inc.D., Ph.D., Director of Hematologic Malignancies Research at the Sarah Cannon Study Institute, Nashville, TN. Tuesday, December 8, 2009, 8:15 a.m., Ernest N.D., Monday Calistoga Pharmaceuticals, 7 December, 2009, 7:45 a.m., Ernest N. Morial Convention Center, Room 243-245 Oral Program: Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Novel Little Molecule Inhibitors In Preclinical Lymphoma Versions Abstract #286:.Yet we condemn the elderly to experiencing this accomplishment because we don’t give them the assets or the care they have to live their final years with dignity. It’s as though we as a culture aren’t prepared to confront this achievement with actions that worth this stage of lifestyle. This report, the to begin its kind, presents a panorama of aging in your community and proposes a plan of action to ensure that old adults in Latin America and the Caribbean not merely survive but thrive, and that the health span in Latin America and the Caribbean boosts with the life span.